CODE THE BODY CAN RUN

Creating the programming language for lifelong health

BIOS IT4 DATASET

Visualisation by Andreas Nicolas Fischer

BIOS has launched a flagship programme to realise a neural-cardiac therapy in partnership with the top pharma R&D, academic and technology organisations in the world.

AUTONOMIC

THERAPY INITIATIVE

CARDIAC DISEASE IS OUR BIGGEST HEALTH CRISIS WITH FEW EFFECTIVE DRUGS

Cardiovascular diseases are responsible for a third of all deaths globally.

However, new cardiovascular disease therapies are very rare due to the high cost and long timescale of trials and the 10,000 to 1 failure rate of new pharmaceutical compounds.

OUR BEACHHEAD WILL BE

TO SURPASS THE BETA BLOCKER FOR CARDIAC DISEASE

By understanding and correcting signals in real time, we can treat chronic cardiac illnesses in an effective, automated and personalized way.

Neural interfaces can be used to form a direct connection with the neurons around the heart and other organs, which offers a whole new class of treatments for cardiovascular disease.

WHEN WE CAN CONTROL OUR NEURAL SIGNALS WE CAN PREVENT THE DETERIORATION IN OUR HEALTH

ECG

RESPIRATORY PRESSURE

BLOOD GLUCOSE

THE AUTONOMIC THERAPY INITIATIVE IS POWERED BY DIGITAL NEURAL BIOMARKERS

BIOS uses neural interfaces & AI to discover the language of the nervous system - a code known as digital neural biomarkers

The Autonomic Therapy Initiative (ATI) leverages these unique neural biomarkers to offer precision unseen before in healthcare - giving personalised, real-time treatment recommendations, shaping the design of new therapies and even replacing current drugs with computer generated neural signals